Tiny radiation seeds target tough head and neck cancers

NCT ID NCT05047094

First seen Dec 08, 2025 · Last updated Apr 21, 2026 · Updated 20 times

Summary

This study is testing a new combination treatment for advanced head and neck cancer that has returned or spread. Doctors will implant tiny radioactive seeds directly into a tumor and combine this with an immunotherapy drug (pembrolizumab). The goal is to see if this two-part approach can better control the cancer in up to 48 participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sharett institute, Hadassah University Hospital - Ein-Kerem

    RECRUITING

    Jerusalem, 91120, Israel

    Contact

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tel-Aviv Medical Center

    NOT_YET_RECRUITING

    Tel Aviv, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.